A prospective study of lifestyle factors and bone health in breast cancer patients who received aromatase inhibitors in an integrated healthcare setting-Reference-Cited by-同舟云学术

A prospective study of lifestyle factors and bone health in breast cancer patients who received aromatase inhibitors in an integrated healthcare setting

Published:2021-02-09 Issue: Volume: Page:
ISSN:1932-2259
Container-title:Journal of Cancer Survivorship
language:en
Short-container-title:J Cancer Surviv

Author:

Kwan Marilyn L.^ORCID,Lo Joan C.,Laurent Cecile A.,Roh Janise M.,Tang Li,Ambrosone Christine B.,Kushi Lawrence H.,Quesenberry Charles P.,Yao Song

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Oncology(nursing),Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11764-021-00993-0.pdf

Reference47 articles.

1. Regan MM, Neven P, Giobbie-Hurder A, Goldhirsch A, Ejlertsen B, Mauriac L, et al. Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-up. Lancet Oncol. 2011;12(12):1101–8.

2. Goss PE, Ingle JN, Pritchard KI, Robert NJ, Muss H, Gralow J, et al. Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years. N Engl J Med. 2016;375(3):209–19.

3. Amir E, Seruga B, Niraula S, Carlsson L, Ocaña A. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis. J Natl Cancer Inst. 2011;103(17):1299–309.

4. Neuner JM, Shi Y, Kong AL, Kamaraju S, Smith EC, Smallwood AJ, et al. Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy. J Cancer Surviv. 2018;12(2):268–75.

5. Early Breast Cancer Trialists' Collaborative, G. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet. 2015;386(10001):1341–52.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A prospective study of vitamin D, proinflammatory cytokines, and risk of fragility fractures in women on aromatase inhibitors for breast cancer;Breast Cancer Research and Treatment;2024-07-08

2. Protective role of exercise on breast cancer-related osteoporosis in women undergoing aromatase inhibitors: A narrative review;Bone Reports;2024-06

3. A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitors;npj Breast Cancer;2024-01-20

4. Analysis of the distinct features of metastasis male breast cancer and its effect on overall survival based on the SEER database compared with female breast cancer;Translational Cancer Research;2023-09

5. Bone protection mechanism of Zuogui Pill in an osteoporosis model of breast cancer rats after endocrine therapy;2023-05-11